Ampicillin use in Acne
Main Article Content
Keywords
acne, ampicillin
Abstract
Introduction: In one author’s experience, ampicillin is an effective alternative antibiotic for acne; however, current literature for ampicillin use in acne is scant. The objective of this study was to demonstrate the response of oral Ampicillin in acne.
Methods: A retrospective analysis of 243 patients with Acne vulgaris treated with Ampicillin 500mg twice daily was conducted. The severity of acne (on a scale of 0 to 3) at the last visit was compared with baseline severity determined at the initial visit. Results were analyzed using the paired samples t-test.
Results: The average severity of acne was reduced from 1.54 to 0.90 (p < 0.001). The average severity was reduced from 1.69 to 1.09 (p < 0.001) among men, and from 1.48 to 0.84 (p < 0.001) among woman. Lastly, average severity was decreased from 1.67 to 1.12 (p < 0.001) in patients with nodulocystic acne, from 1.45 to 0.77 (p < 0.001) with inflammatory acne patients, and from 1.00 to 0.38 (p < 0.001) in patients with comedonal acne.
Limitations: This study was limited by its retrospective nature and analysis of a small patient population. Additionally, a validated acne scoring system was not used due to provider documentation.
Conclusion: To conclude, Ampicillin had a positive effect on our patient’s acne.
References
2. Guzman AK, Choi JK , James WD. Safety and effectiveness of amoxicillin in the treatment of inflammatory acne. Int J Womens Dermatol 2018;4:174-5.
3. Shore RN. Usefulness of ampicillin in treatment of acne vulgaris. J Am Acad Dermatol 1983;9:604-5.
4. Zaenglein AL, Pathy AL, Schlosser BJ, Alikhan A, Baldwin HE, Berson DS et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol 2016;74:945-73.e33.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation.
Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.
Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.